Aspirin Tab - 1
ApprovedSmall molecule
Aspirin Tab - 1 is one of 80 small molecule programs targeting Liver Disease. It is currently in Approved.
2
Indications
2
Total Trials
1
Active Trials
79
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
221 competitors in Liver Disease
#DrugCompanyPhaseTrials
1Mounjaro
Eli LillyPhase 3
Neurontin
VViatris Specialty LLC
Phase 3
Inderal
WWyeth-Lederle Vaccines
Phase 3
Viagra
VViatris Specialty LLC
Phase 3
Sandostatin
Sun PharmaPhase 3
Neupogen
EEastern Cooperative Oncology Group
Phase 3
Retatrutide
Eli LillyPhase 3
Jardiance
Boehringer IngelheimPhase 2
Aspirin Tab - 1
TTaichung Veterans General Hospital
Approved
Chronulac
SSolvay Pharmaceuticals
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Aspirin Tab - 1. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details